全文获取类型
收费全文 | 6761篇 |
免费 | 332篇 |
国内免费 | 94篇 |
专业分类
耳鼻咽喉 | 34篇 |
儿科学 | 154篇 |
妇产科学 | 123篇 |
基础医学 | 746篇 |
口腔科学 | 172篇 |
临床医学 | 386篇 |
内科学 | 1837篇 |
皮肤病学 | 197篇 |
神经病学 | 604篇 |
特种医学 | 344篇 |
外科学 | 1227篇 |
综合类 | 28篇 |
一般理论 | 1篇 |
预防医学 | 167篇 |
眼科学 | 71篇 |
药学 | 366篇 |
中国医学 | 9篇 |
肿瘤学 | 721篇 |
出版年
2023年 | 50篇 |
2022年 | 104篇 |
2021年 | 158篇 |
2020年 | 110篇 |
2019年 | 145篇 |
2018年 | 159篇 |
2017年 | 110篇 |
2016年 | 149篇 |
2015年 | 137篇 |
2014年 | 182篇 |
2013年 | 214篇 |
2012年 | 363篇 |
2011年 | 434篇 |
2010年 | 258篇 |
2009年 | 234篇 |
2008年 | 402篇 |
2007年 | 441篇 |
2006年 | 436篇 |
2005年 | 423篇 |
2004年 | 449篇 |
2003年 | 498篇 |
2002年 | 477篇 |
2001年 | 100篇 |
2000年 | 105篇 |
1999年 | 81篇 |
1998年 | 107篇 |
1997年 | 84篇 |
1996年 | 75篇 |
1995年 | 54篇 |
1994年 | 45篇 |
1993年 | 45篇 |
1992年 | 58篇 |
1991年 | 41篇 |
1990年 | 45篇 |
1989年 | 46篇 |
1988年 | 29篇 |
1987年 | 32篇 |
1986年 | 22篇 |
1985年 | 24篇 |
1984年 | 21篇 |
1983年 | 24篇 |
1982年 | 17篇 |
1981年 | 19篇 |
1980年 | 20篇 |
1979年 | 27篇 |
1978年 | 21篇 |
1977年 | 16篇 |
1976年 | 13篇 |
1975年 | 10篇 |
1968年 | 10篇 |
排序方式: 共有7187条查询结果,搜索用时 15 毫秒
101.
102.
Andrew X. Zhu Richard S. Finn Yoon-Koo Kang Chia-Jui Yen Peter R. Galle Josep M. Llovet Eric Assenat Giovanni Brandi Kenta Motomura Izumi Ohno Bruno Daniele Arndt Vogel Tatsuya Yamashita Chih-Hung Hsu Guido Gerken John Bilbruck Yanzhi Hsu Kun Liang Ryan C. Widau Chunxiao Wang Paolo Abada Masatoshi Kudo 《British journal of cancer》2021,124(8):1388
Background Post hoc analyses assessed the prognostic and predictive value of baseline alpha-fetoprotein (AFP), as well as clinical outcomes by AFP response or progression, during treatment in two placebo-controlled trials (REACH, REACH-2).Methods Serum AFP was measured at baseline and every three cycles. The prognostic and predictive value of baseline AFP was assessed by Cox regression models and Subpopulation Treatment Effect Pattern Plot method. Associations between AFP (≥ 20% increase) and radiographic progression and efficacy were assessed.Results Baseline AFP was confirmed as a continuous (REACH, REACH-2; p < 0.0001) and dichotomous (≥400 vs. <400 ng/ml; REACH, p < 0.01) prognostic factor, and was predictive for ramucirumab survival benefit in REACH (p = 0.0042 continuous; p < 0.0001 dichotomous). Time to AFP (hazard ratio [HR] 0.513; p < 0.0001) and radiographic (HR 0.549; p < 0.0001) progression favoured ramucirumab. Association between AFP and radiographic progression was shown for up to 6 (odds ratio [OR] 5.1; p < 0.0001) and 6–12 weeks (OR 1.8; p = 0.0065). AFP response was higher with ramucirumab vs. placebo (p < 0.0001). Survival was longer in patients with an AFP response than patients without (13.6 vs. 5.6 months, HR 0.451; 95% confidence interval, 0.354–0.574; p < 0.0001).Conclusions AFP is an important prognostic factor and a predictive biomarker for ramucirumab survival benefit. AFP ≥ 400 ng/ml is an appropriate selection criterion for ramucirumab.Clinical Trial Registration ClinicalTrials.gov, REACH () and REACH-2 ( NCT01140347).Subject terms: NCT02435433Oncology, Biomarkers 相似文献
103.
104.
Self‐expanding metallic stent improves histopathological edema compared with transanal drainage tube for malignant colorectal obstruction
下载免费PDF全文
![点击此处可从《Digestive endoscopy》网站下载免费的PDF全文](/ch/ext_images/free.gif)
105.
106.
Endoscopic ultrasound‐guided antegrade biliary stenting for unresectable malignant biliary obstruction in patients with surgically altered anatomy: Single‐center prospective pilot study
下载免费PDF全文
![点击此处可从《Digestive endoscopy》网站下载免费的PDF全文](/ch/ext_images/free.gif)
107.
New therapeutic approach for impaired arteriogenesis in diabetic mouse hindlimb ischemia. 总被引:1,自引:0,他引:1
Shyamal Chandra Bir Masatoshi Fujita Akira Marui Keiichi Hirose Yoshio Arai Hisashi Sakaguchi Yuhong Huang Jiro Esaki Tadashi Ikeda Yasuhiko Tabata Masashi Komeda 《Circulation journal》2008,72(4):633-640
BACKGROUND: The combined treatment of sustained-release basic fibroblast growth factor (Sr-bFGF) and a 5-hydroxytryptamine(2A) blocker, sarpogrelate, was evaluated to see whether it reversed the impaired collateral circulation in diabetic (DM) mouse hindlimb ischemia. METHOD AND RESULTS: Diabetic and normal mice with ischemic hindlimb were randomly assigned to 1 of 5 experimental groups (no treatment, sarpogrelate 50 mg . kg(-1) . day(-1), 20 microg or 50 microg Sr-bFGF and a combined treatment of 20 microg Sr-bFGF and sarpogrelate), and treated for 4 weeks. Tissue blood perfusion (TBP), vascular density (angiogenesis) and the number of mature vessels (arteriogenesis) were checked by the use of standard methods. Although angiogenesis was comparable (161+/-14 vs 154+/-12 vessels/mm(2)), the laser Doppler perfusion image index (LDPII) (0.43+/-0.11 (SD) vs 0.63+/-0.08, p<0.05) and arteriogenesis (8+/-3 vs 12+/-4 vessels/mm(2), p<0.05) were significantly lower in DM mice than those in normal mice. The dose of Sr-bFGF for the sufficient number of mature vessels (>or=45 vessels/mm(2)) and LDPII (>or=0.9) was 20 microg for the normal mice, and 50 microg for the DM mice, which was reduced with the aid of sarpogrelate. Conclusions A combined therapy of Sr-bFGF and sarpogrelate is effective for neovascularization to reverse the impaired arteriogenesis and TBP in DM mice. 相似文献
108.
Dr. Hiroshi Kandeko MD Terunori Mitsuma MD Hirofumi Nagai MD Masatoshi Harada MD Hiroshi Kotera MD Atsushi Furusawa MD Kimitomo Morise MD 《Digestive diseases and sciences》1995,40(1):160-165
Omeprazole markedly inhibits basal and stimulated gastric acid secretion and has the ability to produce hypergastrinemia and hyperplasia of enterochromaffin-like cells in humans. On the other hand, paunotol, an acyclic diterpene alcohol, has been reported to inhibit gastrin release by stimulating endogenous secretin release. We investigated the effect of plaunotol on serum gastrin levels after six to eight weeks of omeprazole (20 mg/day) administration in 22 patients (16 males, 6 females; mean age 52.3, range 36–70 years) with peptic ulcer disease. The patients were randomized to the following two groups: 11 subjects with omerprazole alone (single group) and 11 with omeprazole plus plaunotol (240 mg/day) (combination group) treatment. There were no significant differences between the two groups concerning age, sex, ulcer stage, ulcer history, environmental factors, andHelicobacter pylori (HP) prevalence. After complete drug(s) administration, serum immunoreactive (ir) -gastrin levels increased significantly in the single group (P<0.001) in contrast to the combination group, and plaunotol significantly inhibited hypergastrinemia induced by omeprazole administration (P<0.001). Significant increases in serum ir-calcitonin gene-related peptide concentrations were observed in the combination group compared to the single group (P<0.05). However, there were no significant changes in serum ir-secretin, somatostatin, and vasoactive intestinal polypeptide levels as well as ulcer healing and HP prevalence between the two groups. These findings suggest that plaunotol may suppress hypergastrinemia induced by long-term omeprazole administration, at least partly, via a certain brain-gut hormone affecting gastrin release. 相似文献
109.
110.
Tomohiro Watanabe Masatoshi Kudo Tsutomu Chiba Yoshio Wakatsuki 《Hepatology research》2008,38(5):441-449
The liver has been considered as a tolerogenic organ in the sense that favors the induction of peripheral tolerance. The administration of antigens (Ags) via the portal vein causes tolerance, which is termed portal vein tolerance and can explain the occurrence of tolerogenic responses in the liver. Here we discuss the fundamental mechanisms accounting for portal vein tolerance. Antigen-presenting cells (APCs) in the liver, especially dendritic cells and sinusoidal endothelial cells, have limited the ability to produce pro-inflammatory cytokines upon stimulation with endotoxin, an effect that could be due to the continuous exposure to bacterial Ags derived from intestinal microflora. Ag presentation by liver APCs results in T cell tolerance through clonal deletion and selection of regulatory T cells. Thus, APCs with immunosuppressive functions are associated with the achievement of portal vein tolerance via the induction of clonal deletion and generation of regulatory T cells. 相似文献